Atharva Poly-Plast IPO Review — Should You Apply?
Moderate Sentiment
Reasonable grey market premium and moderate subscription suggest balanced market interest.
Atharva Poly-Plast IPO Review Summary
Atharva Poly-Plast paired sector-beating margins with strong returns — a 19.32% EBITDA margin and 40.63% RONW — at a fair 16.29x valuation, drawing a measured 3.58x subscription.
The caveats are small scale, polymer-cost exposure, and a thin NAV. It suited investors who like quality micro-caps at a fair price; compare it on our IPO performance page. This is informational analysis based on available data, not investment advice.
Who Should Consider This IPO?
This IPO suited investors comfortable with micro-cap risk who value strong margins and returns at a reasonable price. New to applying? Our how to apply for an IPO guide covers the steps.
It was less suited to those seeking scale and liquidity or wary of commoditised-plastics cyclicality. Applications are usually made via a discount demat account using UPI.
Detailed Investment Analysis
At the upper band of ₹60, Atharva Poly-Plast was valued at 16.29x earnings on an EPS of ₹3.38 — a fair multiple that reflects its strong margins and returns without being cheap. The pricing sat in reasonable middle ground.
The financial quality stands out for a micro-cap. A 19.32% EBITDA margin is well above the norm for commoditised plastics, and the 40.63% RONW with 35.31% ROCE shows strong capital efficiency. Revenue of ₹42.42 Cr keeps it small, though.
The risks are the familiar plastics ones — polymer input-cost volatility, competition, and client concentration — plus the fragility that comes with small scale. The low NAV of ₹10.53 also means much of the value rests on sustaining current earnings.
Investor demand was moderate, with the issue subscribed 3.58x overall — a measured response rather than a stampede. With the listing still ahead at the time of writing, the strong margins and returns were the core attraction. Our IPO profit calculator can size a position. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Strengths
- A strong 19.32% EBITDA margin, well above the norm for commoditised plastic products.
- Excellent capital efficiency, with RONW of 40.63% and ROCE of 35.31%.
- A fair valuation at 16.29x earnings, reasonable given the quality of the returns.
- A 100% fresh issue means the full ₹27 Cr funds growth.
- Solid profitability for the size, with net profit of ₹4.73 Cr on revenue of ₹42.42 Cr.
Risks & Concerns
- Exposure to volatile polymer input costs, which can squeeze margins in a competitive segment.
- Very small scale, with revenue of ₹42.42 Cr, makes the business fragile and growth lumpy.
- A low NAV of ₹10.53 means the valuation leans heavily on sustaining current earnings.
- Client concentration is common at this size and could dent revenue if a key account is lost.
- Thin SME liquidity and a large per-lot ticket constrain post-listing participation.
Want Full IPO Data?
This review focuses on analysis. For complete IPO details — GMP history, subscription day-wise, financial tables, allocation breakdown, and registrar/lead manager info — visit the full data page.
View Atharva Poly-Plast IPO Full Details →Frequently Asked Questions
What was Atharva Poly-Plast IPO's price band and lot size?
Atharva Poly-Plast was priced at ₹55 to ₹60 per share, with a lot of 2,000 shares — a per-lot value of about ₹1.20 lakh at the upper band. The face value was ₹10.
How strong are Atharva Poly-Plast's financials?
Strong for its size: a 19.32% EBITDA margin and excellent return ratios of 40.63% RONW and 35.31% ROCE, though revenue of ₹42.42 Cr keeps it a micro-cap.
Was Atharva Poly-Plast IPO fairly valued?
Fairly — at 16.29x earnings on an EPS of ₹3.38, the price reflected its strong margins and returns without being cheap.
What are the key risks in Atharva Poly-Plast IPO?
Polymer input-cost volatility, small scale and client concentration, and a low NAV of ₹10.53 that leaves the valuation dependent on sustaining earnings.
Disclaimer: This review is informational analysis based on publicly available data. It is NOT investment advice. The verdict is a data-driven signal, not a recommendation to buy or sell. IPO GMP is unofficial and unregulated. Consult a SEBI-registered financial advisor before making investment decisions. Stock market investments are subject to market risks.